COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Study to Evaluate Bioavailability of a Single 12 mg Dose of Perampanel for Three Intravenous Infusion Durations Relative to a Single 12 mg Perampanel Oral Tablet in Healthy Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03376997
Recruitment Status : Completed
First Posted : December 19, 2017
Last Update Posted : September 7, 2018
Information provided by (Responsible Party):
Eisai Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : February 16, 2018
Actual Study Completion Date : February 16, 2018